Total Payments
$2,197
2023 Payments
$117.37
Companies
17
Transactions
156
Medicare Patients
17,126
Medicare Billing
$738,309
Payment Breakdown by Category
Food & Beverage$2,197 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,197 | 156 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $698.04 | 55 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $284.91 | 20 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $214.78 | 16 | $0 (2021) |
| PFIZER INC. | $202.99 | 13 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $187.21 | 11 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $155.19 | 12 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $105.51 | 7 | $0 (2019) |
| Amgen Inc. | $74.38 | 5 | $0 (2020) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $57.30 | 4 | $0 (2019) |
| Abbott Laboratories | $52.32 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $117.37 | 7 | E.R. Squibb & Sons, L.L.C. ($53.97) |
| 2022 | $86.90 | 6 | Janssen Pharmaceuticals, Inc ($44.90) |
| 2021 | $330.42 | 21 | Janssen Pharmaceuticals, Inc ($175.13) |
| 2020 | $280.19 | 18 | Janssen Pharmaceuticals, Inc ($87.43) |
| 2019 | $632.04 | 46 | Janssen Pharmaceuticals, Inc ($215.15) |
| 2018 | $434.29 | 35 | Janssen Pharmaceuticals, Inc ($122.73) |
| 2017 | $315.76 | 23 | Janssen Pharmaceuticals, Inc ($52.70) |
All Payment Transactions
156 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/08/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: CARDIOVASCULAR | ||||||
| 07/18/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.60 | General |
| Category: Cardiovascular | ||||||
| 05/12/2023 | Teleflex LLC | TURNPIKE (Device) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: Interventional Access | ||||||
| 05/09/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $21.21 | General |
| Category: Cardiovascular | ||||||
| 04/04/2023 | SANOFI-AVENTIS U.S. LLC | MULTAQ (Drug) | Food and Beverage | In-kind items and services | $16.38 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/21/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.16 | General |
| Category: Cardiovascular | ||||||
| 01/04/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.71 | General |
| Category: Cardiovascular | ||||||
| 09/26/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/06/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Rare Disease | ||||||
| 07/26/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/14/2022 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.44 | General |
| Category: Cardiovascular | ||||||
| 05/16/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.71 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/12/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/24/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.27 | General |
| Category: DIABETES | ||||||
| 08/23/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/02/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/28/2021 | Medtronic, Inc. | CareLink (Device) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Cardiac Diagnostics and Monitoring | ||||||
| 07/26/2021 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/24/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/03/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $26.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/19/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/12/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 3,153 | 3,941 | $665,837 | $136,419 |
| 2022 | 34 | 3,635 | 4,689 | $708,405 | $145,636 |
| 2021 | 40 | 4,897 | 5,860 | $959,052 | $210,976 |
| 2020 | 43 | 5,441 | 6,980 | $1.1M | $245,279 |
Total Patients
17,126
Total Services
21,470
Medicare Billing
$738,309
Procedure Codes
157
All Medicare Procedures & Services
157 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 415 | 505 | $110,090 | $35,089 | 31.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 420 | 441 | $134,773 | $22,211 | 16.5% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 246 | 250 | $75,250 | $14,259 | 18.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 49 | 106 | $23,320 | $9,392 | 40.3% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 790 | 1,209 | $37,820 | $7,211 | 19.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 41 | 46 | $18,998 | $5,941 | 31.3% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 27 | 27 | $35,370 | $5,022 | 14.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 77 | $11,858 | $4,492 | 37.9% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 263 | 271 | $34,959 | $4,296 | 12.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 35 | $9,835 | $3,380 | 34.4% |
| 92960 | External shock to heart to regulate heart beat | Facility | 2023 | 33 | 42 | $24,864 | $3,351 | 13.5% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 263 | 271 | $28,726 | $2,834 | 9.9% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 76 | 147 | $26,460 | $2,744 | 10.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 24 | 24 | $5,424 | $2,555 | 47.1% |
| 93296 | Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | Office | 2023 | 67 | 117 | $17,901 | $1,848 | 10.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 12 | 12 | $11,004 | $1,787 | 16.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 19 | 19 | $6,232 | $1,775 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 26 | 26 | $3,796 | $1,225 | 32.3% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Facility | 2023 | 66 | 72 | $14,976 | $1,216 | 8.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 18 | 20 | $3,320 | $1,200 | 36.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 29 | 30 | $4,920 | $1,150 | 23.4% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 18 | 18 | $2,952 | $670.14 | 22.7% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 21 | 21 | $4,032 | $533.71 | 13.2% |
| 93280 | Programming of dual lead pacemaker system | Facility | 2023 | 16 | 19 | $4,009 | $502.92 | 12.5% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 16 | 16 | $2,304 | $453.76 | 19.7% |
About Dr. Qaiser Rasheed, MD
Dr. Qaiser Rasheed, MD is a Cardiovascular Disease healthcare provider based in Clinton, Iowa. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396702056.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Qaiser Rasheed, MD has received a total of $2,197 in payments from pharmaceutical and medical device companies, with $117.37 received in 2023. These payments were reported across 156 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($2,197).
As a Medicare-enrolled provider, Rasheed has provided services to 17,126 Medicare beneficiaries, totaling 21,470 services with total Medicare billing of $738,309. Data is available for 4 years (2020–2023), covering 157 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Clinton, IA
- Active Since 04/27/2006
- Last Updated 03/15/2013
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1396702056
Products in Payments
- XARELTO (Drug) $698.04
- ELIQUIS (Drug) $437.65
- ENTRESTO (Drug) $171.91
- JARDIANCE (Drug) $149.49
- BRILINTA (Drug) $139.34
- Corlanor (Drug) $74.38
- PRALUENT ALIROCUMAB INJECTION (Biological) $60.49
- LifeVest (Device) $57.30
- CAMZYOS (Drug) $50.25
- PRADAXA (Drug) $48.99
- PRALUENT (Biological) $45.02
- Optis Coronary Imaging System (Device) $40.29
- MULTAQ (Drug) $34.31
- SAMSCA (Drug) $30.48
- VERQUVO (Drug) $29.06
- CareLink (Device) $20.33
- AirSense (Device) $20.03
- TURNPIKE (Device) $17.06
- TRADJENTA (Drug) $16.30
- ANDEXXA (Biological) $15.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Clinton
Dr. Ieon Dawson, M.d.,F.a.c.c, M.D.,F.A.C.C
Cardiovascular Disease — Payments: $6,791
Cardiovascular Disease $6,791
Dr. John Patterson, M.d, M.D
Cardiovascular Disease — Payments: $2,660
Cardiovascular Disease $2,660
Dr. Ali Albaghdadi, M.d, M.D
Cardiovascular Disease — Payments: $1,757
Cardiovascular Disease $1,757
Dr. Saadi Albaghdadi, M.d, M.D
Cardiovascular Disease — Payments: $1,653
Cardiovascular Disease $1,653
Dr. Glenn Jaucian, Md, MD
Cardiovascular Disease — Payments: $1,602
Cardiovascular Disease $1,602
Dr. Raj Samtani, M.d, M.D
Cardiovascular Disease — Payments: $919.74
Cardiovascular Disease $919.74